Herbalife Ltd $HLF Shares Bought by Invenomic Capital Management LP

Invenomic Capital Management LP boosted its stake in shares of Herbalife Ltd (NYSE:HLF) by 82.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 768,031 shares of the company’s stock after acquiring an additional 347,401 shares during the period. Invenomic Capital Management LP owned about 0.74% of Herbalife worth $9,900,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd acquired a new position in Herbalife during the fourth quarter worth $32,000. Aster Capital Management DIFC Ltd acquired a new position in Herbalife during the third quarter worth $35,000. Advisory Services Network LLC acquired a new position in Herbalife during the third quarter worth $65,000. Quarry LP raised its position in Herbalife by 49,105.3% during the third quarter. Quarry LP now owns 9,349 shares of the company’s stock worth $79,000 after acquiring an additional 9,330 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in Herbalife by 512.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 6,544 shares of the company’s stock worth $84,000 after acquiring an additional 5,476 shares during the period.

Herbalife Trading Down 1.5%

Shares of HLF opened at $11.65 on Thursday. Herbalife Ltd has a 12-month low of $7.56 and a 12-month high of $20.40. The firm has a 50-day moving average price of $13.86 and a 200 day moving average price of $14.87. The firm has a market capitalization of $1.21 billion, a P/E ratio of 5.11, a P/E/G ratio of 0.70 and a beta of 0.88.

Herbalife (NYSE:HLF) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same quarter in the prior year, the firm posted $0.59 earnings per share. Herbalife’s quarterly revenue was up 7.8% on a year-over-year basis. Equities research analysts predict that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.

Insider Activity

In other Herbalife news, COO Troy Hicks sold 38,377 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $12.93, for a total transaction of $496,214.61. Following the completion of the transaction, the chief operating officer owned 9,062 shares of the company’s stock, valued at $117,171.66. This trade represents a 80.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Frank Lamberti sold 134,982 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the transaction, the insider directly owned 36,624 shares of the company’s stock, valued at approximately $494,424. This trade represents a 78.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 191,296 shares of company stock valued at $2,551,678. 5.13% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have weighed in on HLF shares. Citigroup restated a “buy” rating and set a $21.00 price objective (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Wall Street Zen upgraded shares of Herbalife from a “buy” rating to a “strong-buy” rating in a research report on Saturday, April 18th. Zacks Research cut shares of Herbalife from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. Royal Bank Of Canada reduced their target price on shares of Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a research report on Tuesday, April 28th. Finally, Mizuho set a $17.00 target price on shares of Herbalife in a research report on Monday, May 4th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.80.

Herbalife Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.